Skip to main content

Anti-Cancer Drug Design is now published as Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics.

Publisher: Cognizant Communication Corporation

Volume 15, Number 2, 2000
Purchase this issue

Characterization of anticancer agents by their growth inhibitory activity and relationships to mechanism of action and structure
pp. 79-98(20)
Authors: Keskin, O; Bahar, I; Jernigan, RL; Beutler, JA; Shoemaker, RH; Sausville, EA; Covell, DG

Favourites:
ADD

Biological properties of 5,11-dimethyl-6H-pyrido[3,2-b]carbazoles: a new class of potent antitumor drugs
pp. 109-118(10)
Authors: Moinet-Hedin, V; Tabka, T; Poulain, L; Godard, T; Lechevrel, M; Saturnino, C; Lancelot, J-C; Le Talaël, J-Y; Gauduchon, P

Favourites:
ADD

Synthesis of new homochiral bispyrrolidines as potential DNA cross-linking antitumour agents
pp. 119-126(8)
Authors: Anderson, FM; O'Hare, CC; Hartley, JA; Robins, DJ

Favourites:
ADD

Novobiocin-induced VP-16 accumulation and MRP expression in human leukemia and ovarian carcinoma cells
pp. 127-134(8)
Authors: Rappa, G; Murren, JR; Johnson, L-M; Lorico, A; Sartorelli, AC

Favourites:
ADD

The interaction of chalcones with tubulin
pp. 135-141(7)
Authors: Lawrence, NJ; McGown, AT; Ducki, S; Hadfield, JA

Favourites:
ADD

Photosensitizing properties of palladium-tetraphenylporphycene on cultured tumour cells
pp. 143-150(8)
Authors: Cañete, M; Ortiz, A; Juarranz, A; Villanuev, A; Nonell, S; Borrell, JI; Teixidó, J; Stockert, JC

Favourites:
ADD

The complete issue is available for purchase

$60.00

Purchasing this issue will give you access to all of the articles listed above for 2 days. You may also purchase articles individually by visiting the abstract page of the article. The exact price (including tax) will be displayed in your shopping cart before you check out. You will be able to remove this item from your shopping cart at any time before you have completed check-out.

Add to cart

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more